Anesthesiology News Presents29 Apr 2025

Tariffs Expected to Worsen Shortages, Increase Drug Prices and Hurt Healthcare

From never-ending staffing shortages to a myriad of financial challenges from the COVID-19 pandemic, the past several years have been exceptionally difficult on the United States' healthcare system. Although many institutions have weathered the storm, some have resorted to private equity, some are on life support and others have closed their doors. Now, hospitals and health systems (and our country at large) are facing another unforeseen obstacle: tariffs on imports into this country. The presidential order imposes a 10% tariff on all countries, as well as individualized higher tariffs on the countries “with which the United States has the largest trade deficits.”

As the vast majority of supplies that hospitals depend upon to safely operate are imported (such as gloves, gowns, machines, medicines and IV supplies), the tariffs will undoubtedly increase costs at every level. Additionally, the tariffs are likely to have a significant harmful impact on the country’s pharmaceutical supply chain, particularly in the generic space, and could exacerbate existing drug shortages. A significant portion of active pharmaceutical ingredients (APIs) and finished medications are manufactured abroad, with a substantial percentage of APIs originating from India and China—countries that are being hit with major increases in tariffs.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(60)

New Research Links Cannabis Use With Lung Cancer

Historically, there has been no definitive link between smoking cannabis and lung cancer; however, new research suggests otherwise. The retrospective cohort study used 20 years of deidentified elect...

27 Juli 7min

Clearing the Air – The Science and Sustainability of Desflurane in Anesthesia

In this podcast, an anesthesiologist (TJ Gan) and an environmental scientist (Michelle Cain) discuss the use of desflurane with a focus on environmental considerations, as well as clinical outcomes an...

5 Feb 24min

WHO Addresses Cannabinoid Hyperemesis Syndrome

The WHO has added cannabinoid hyperemesis syndrome (CHS) to its diagnostic manual, establishing a new dedicated ICD-10-CM (International Classification of Diseases, 10th Revision, Clinical Modificatio...

7 Jan 17min

Are My Meds Real? Counterfeit Production on the Rise

As many popular medications in the United States have continued to increase in price, there has been a related rise in the number of counterfeit medications being produced and sold, specifically onlin...

1 Juli 20256min

A Murdered CEO, Anesthesia Reimbursement (Almost) Restricted and Ubiquitous Corporate ‘Greedflation’: Signs of the Times?

A healthcare company executive is shot in the back, murdered in cold blood; an angry populace chafes at the rising costs of health insurance and denials in coverage; and a privately held insurance com...

8 Maj 20254min

The L.A. Wildfires Bring Massive Health Concern

The Los Angeles wildfires have destroyed thousands of homes and stores, and left entire communities in ash and rubble. And while lives have already been lost, experts are now discussing the long-term ...

28 Jan 20258min

The Growing Epidemic of Elderly Abuse

The number of senior citizens is growing rapidly; individuals aged 65 and older increased from 39.6 million in 2009 to 54.1 million in 2019 (a 36% increase) and is projected to reach 94.7 million by 2...

17 Juli 202412min